Insights

Gathering insights about DIA…

Similar companies to DIA

DIA Tech Stack

DIA uses 8 technology products and services including Hoefler&Co, Alpine.js, jQuery, and more. Explore DIA's tech stack below.

Hoefler&Co
Font Scripts
Alpine.js
Javascript Frameworks
jQuery
Javascript Libraries
RSS
Miscellaneous
Tailwind CSS
UI Frameworks
Twitter
Widgets
Linkedin
Widgets
Facebook
Widgets

Media & News

DIAX: The Covered Call Dilemma
DIAX offers quarterly income through a covered call strategy, capping upside potential for steady income, ideal for income-focused investors. The fund writes call options on the S&P 500 Index, while have a long position in DJIA stocks. DIAX's higher expense ratio (0.93%) and capped growth potential may lead to capital erosion over time, especially if distributions aren't reinvested.
Nov 16, 2024 | seekingalpha.com
Six Nuveen Closed-End Funds Announce Availability of 19(a) Notices
NEW YORK--(BUSINESS WIRE)--The 19(a) distribution notices for six Nuveen closed-end funds are now available. These informational notices provide further details on the sources of the funds' regular quarterly distributions and follows the most recent quarterly distribution announcements. The full text of these notices is available below or on the Nuveen website via Distribution Source Estimates. Important Information Regarding Distributions March 28, 2024: THIS NOTICE IS FOR INFORMATIONAL PURPOS.
Mar 28, 2024 | www.businesswire.com
DIAX: The Basis Is Still There, Keep Avoiding This Buy-Write CEF
Nuveen Dow 30 Dynamic Overwrite Fund is a buy-write CEF that aims to replicate the Dow Jones index. The fund's complex risk factor, the SPY/DIA basis, has hindered its performance and is not properly disclosed. Retail investors would be better off buying DIA outright and writing their own call options rather than investing in DIAX.
Mar 12, 2024 | seekingalpha.com
Nuveen Closed-End Funds Declare Distributions
NEW YORK--(BUSINESS WIRE)--Several Nuveen closed-end funds have declared distributions. These funds represent investment strategies for investors seeking diversified sources of cash flow to prepare for and sustain their retirement income needs. For further information regarding fund distributions, including earnings, undistributed net investment income, and notices, please visit www.nuveen.com/cef. Additionally, several leveraged municipal closed-end funds have announced distribution rate incre.
Mar 01, 2024 | www.businesswire.com
DIAX: Not A Great Volatility Reduction Play
Nuveen Dow 30 Dynamic Overwrite Fund aims to provide attractive total returns with less volatility than the Dow Jones Industrial Average. DIAX has delivered below market returns historically but has failed to deliver below market volatility. The Fund trades at a significant discount to NAV, but the dynamic nature of options exposure makes it a difficult arbitrage play.
Nov 12, 2023 | seekingalpha.com
The Key Selling Point Of The 8.1% Yielding DIAX
Selling calls on long positions provides downside protection and shelters investors from stock volatility. The Nuveen Dow 30 Dynamic Overwrite Fund writes covered calls on a portion of its equity portfolio to reduce volatility. We examine whether this 8% yielding fund meets our buying criteria.
Aug 23, 2023 | seekingalpha.com
DIAX: DJIA Exposure With An Overwrite Strategy
Nuveen Dow 30 Dynamic Overwrite Fund (DIAX) is trading at a larger discount compared to its historical level, potentially indicating an attractive opportunity. The fund aims to offer regular distributions with less volatility than the Dow Jones Industrial Average (DJIA) by investing in an equity portfolio and selling call options. However, the fund's odd positioning of writing index calls on indexes that they aren't replicating in their underlying portfolio presents a potential risk.
Jun 01, 2023 | seekingalpha.com

DIA's Email Address Formats

DIA uses at least 1 format(s):

DIA Email Formats	Example	Percentage
First.Last@diaglobal.org	John.Doe@diaglobal.org	97%
FirstL@diaglobal.org	JohnD@diaglobal.org	1%
First_Last@diaglobal.org	John_Doe@diaglobal.org	1%
Last@diaglobal.org	Doe@diaglobal.org	1%

Frequently Asked Questions

Where is DIA's headquarters located?

DIA's main headquarters is located at 21 Dupont Circle NW Suite 300 Washington, DC 2003 US. The company has employees across 6 continents, including North AmericaEuropeSouth America.

What is DIA's phone number?

You can contact DIA's main corporate office by phone at

+1-303-342-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is DIA's stock symbol?

DIA is a publicly traded company; the company's stock symbol is DIAX.

What is DIA's official website and social media links?

DIA's official website is diaglobal.org and has social profiles on LinkedIn.

How much revenue does DIA generate?

As of November 2024, DIA's annual revenue reached $35M.

What is DIA's SIC code NAICS code?

DIA's SIC code is 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does DIA have currently?

As of November 2024, DIA has approximately 467 employees across 6 continents, including North AmericaEuropeSouth America. Key team members include Chief Financial Officer: J. F.Chief Financial Officer: J. W.Chief Financial Executive For Masint And Technical Collections Directorate: K. F.. Explore DIA's employee directory with LeadIQ.

What industry does DIA belong to?

DIA operates in the Pharmaceutical Manufacturing industry.

What technology does DIA use?

DIA's tech stack includes Hoefler&CoAlpine.jsjQueryRSSTailwind CSSTwitterLinkedinFacebook.

What is DIA's email format?

DIA's email format typically follows the pattern of . Find more DIA email formats with LeadIQ.

When was DIA founded?

DIA was founded in 1964.

DIA

Pharmaceutical ManufacturingDistrict of Columbia, United States201-500 Employees

DIA is the leading global life science membership association driving collaboration in drug, device, and diagnostics development in pursuit of a healthier world. 

Founded in 1964 with headquarters in Washington, D.C., and offices in Europe and Asia, DIA provides unparalleled networking opportunities, educational resources, scientific research publications, and professional development programs to members in more than 80 countries.